Sponsor or institution

Clinical trials and research at Alpha Biopharma (Jiangsu) Co., Ltd.

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Zorifertinib with Osimertinib for NSCLC with Meningeal Spread

  This study tests whether giving Zorifertinib together with Osimertinib is safe and effective for people with advanced NSCLC whose cancer has spread to the membranes around the brain and spine after Osimertinib treatment.

  Recruiting at 5 sites Phase 1 Alpha Biopharma (Jiangsu) Co., Ltd. · Beijing, Beijing Municipality and 4 other locations · NCT07361705

• Zorifertinib as first-line therapy for EGFR‑mutant advanced lung cancer with brain or leptomeningeal spread

  This study will try zorifertinib as first treatment for people with EGFR‑mutant advanced non‑small cell lung cancer that has spread to the brain or leptomeninges and compare outcomes with other EGFR‑targeted treatments.

  Recruiting at 4 sites Alpha Biopharma (Jiangsu) Co., Ltd. · Hefei, Anhui and 33 other locations · NCT07143045

Quick answers

How many clinical trials run by Alpha Biopharma (Jiangsu) Co., Ltd. are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →